Post Date:Feb-08-22
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53
Author: AcceGen R&D TeamDate Published: 08-Feb-22
- Authors: Patrizia Malkomes, Ilaria Lunger, Elsie Oppermann, Khalil Abou-El-Ardat, Thomas Oellerich, Stefan Günther, Can Canbulat, Sabrina Bothur, Frank Schnütgen, Weijia Yu, Susanne Wingert, Nadine Haetscher, Claudia Catapano, Marina S. Dietz, Mike Heilemann, Hans-Michael Kvasnicka, Katharina Holzer, Hubert Serve, Wolf Otto Bechstein & Michael A. Rieger
- Journal: Oncogene
- DOI: 10.1038/s41388-021-01847-w
- Cited AcceGen Product/Service: p53 knockout colon cancer cell line HCT-116
Copyright - Unless otherwise stated all contents of this website are AcceGen™ All Rights Reserved – Full details of the use of materials on this site please refer to AcceGen Editorial Policy – Guest Posts are welcome, by submitting a guest post to AcceGen you are agree to the AcceGen Guest Post Agreement – Any concerns please contact marketing@accegen.com
